Skip to main content
CVSACovista Inc.Buy Wait6.3·$126.50
Buy WaitModerate Confidence
Investment thesis

Covista screens attractively valued at a forward P/E of 13.2 times and a PEG of 0.88, underpinned by four consecutive earnings beats averaging more than 11% above consensus; the chief offset is negative price momentum that has not cleared the minimum threshold, keeping the entry setup cautious despite sound fundamentals.

Thesis pillars

  • Negative Momentum Near Term Headwind↓Deteriorating
  • Attractive Forward Valuation Low Peg→Stable
  • Solid Piotroski Financial Health→Stable
  • +1 more pillar — see the Why tab for full reasoning

Pillars as of Jul 3, 2026, based on the 10-K filed Aug 6, 2026

Full reasoning →

Open full analysis

Covista Inc. (CVSA) Stock Analysis

Buy WaitVALUE-TRAP 1/5GrowthQualityModerate Confidence

Consumer Defensive · Education & Training Services

Earnings today — results expected after close (2026-10-29). Expect elevated volatility around the report — consider waiting for post-earnings price action before new entries.

Wait for pullback to $119.32. At $126.50 the A.R:R is 1.1:1 — below the 1.5:1 minimum for BUY_NOW. Engine's entry $119.32 (Ma200 Sticky) is the shallowest technical level that clears the 2:1 A.R:R minimum. Key risk: Thin upside margin: 6.7%.

Covista is America's largest healthcare educator, serving 100,000 students and supported by an alumni network of 400,000 across five accredited institutions: Chamberlain University ("Chamberlain"), Walden University ("Walden"), American University of the Caribbean School of... Read more

$126.50+6.7% A.UpsideScore 6.3/10#4 of 14 Education & Training Services
QualityF-score8 / 9FCF yield7.56%
Entry $119.32(Ma200 Sticky)Stop $111.70Target $134.94(analyst − 15%)A.R:R 1.1:1
Analyst consensus$158.75+25.5%4 analysts
$134.94our TP
$126.50price
$158.75mean
$175

Wait for pullback to $119.32. At $126.50 the A.R:R is 1.1:1 — below the 1.5:1 minimum for BUY_NOW. Engine's entry $119.32 (Ma200 Sticky) is the shallowest technical level that clears the 2:1 A.R:R minimum. Key risk: Thin upside margin: 6.7%. Chart setup: No clear chart pattern; technical signals are mixed. Earnings today. Wait until post-earnings. Score 6.3/10, moderate confidence.

Passes 5/9 gates (positive momentum, clean insider activity, news events none recent, semi cycle peak clear, materials cycle peak clear). Fails on favorable risk/reward ratio and earnings proximity 0d<=7d. Suitability: aggressive.

news + 30-day 8-K events · 5-min refresh

Recent developments

updated 2026-10-29
TrendMatrix Research · upcoming catalyst calendar

Upcoming dated catalysts

Thu, Oct 29, 2026Earnings today — results expected after close· next earnings call

Thesis

Rewards
Sector modifier (Consumer Defensive): +0.8
Attractive valuation
Strong growth profile
Risks
Thin upside margin: 6.7%

Key Metrics

P/E (TTM)16.5
P/E (Fwd)12.6
Mkt Cap$4.3B
EV/EBITDA10.8
Profit Mgn12.9%
ROE18.6%
Rev Growth9.7%
Beta0.65
DividendNone
Rating analysts10

Quality Signals

Piotroski F8/9MoatNarrow

Options Flow

P/C1.54bearish
IV70%elevated

Material Events(8-K, last 90d)

  • 2026-07-28Item 5.02MEDIUM
    (d) The Covista Inc. ("Covista") Board of Directors (the "Board") has appointed Ms. Emily Chiu and Ms. Leslie Storms as independent members of Covista's Board effective August 17, 2026. Ms. Chiu and Ms. Storms will stand for re-election at Covista's 2026 annual meeting of stockholders.
    SEC filing →

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Editorial policy

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. People who build TrendMatrix, or entities they control, may hold positions, long or short, in securities it covers, and may trade them at any time. Positions are not disclosed individually. Verdicts are generated by an automated model applied by the same rules to every covered stock, and are not adjusted for any position held by the people who build TrendMatrix. We do not accept payment from issuers for coverage.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Rating Breakdown

10 dimensions · all in-band

GatesA.R:R 1.1 < 1.5@spotEARNINGS PROXIMITY 0d<=7dMomentum 5.0<5.5 (soft — BUY_NOW allowed but watch)Executive change: officer departure/appointmentMomentum 5.0>=4.5Insider activity: OKNEWS EVENTS NONE RECENTSEMI CYCLE PEAK CLEARMATERIALS CYCLE PEAK CLEARSuitability: Aggressive
RSI
40 · Neutral
↓ 20D MA↓ 50D MA↑ 200D MAGOLDEN CROSSSupport $122.36Resistance $133.78

Price Targets

$112
$119
$135
A.Upside+6.7%
A.R:R1.1:1

Position Sizing

ConvictionNone
Suggested %0.5%
Max %1%
RegimeRisk-Off

Risk Alerts

! Earnings today - binary event risk
! asymmetry at 1.1 (below the engine's 1.5 threshold)@spot
! EARNINGS_PROXIMITY:0d<=7d

Earnings

B
B
B
B
4/4 beats
Next Earnings2026-10-29 (Earnings today — results expected after close)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is CVSA stock a buy right now?

Wait for pullback to $119.32. At $126.50 the A.R:R is 1.1:1 — below the 1.5:1 minimum for BUY_NOW. Engine's entry $119.32 (Ma200 Sticky) is the shallowest technical level that clears the 2:1 A.R:R minimum. Key risk: Thin upside margin: 6.7%. Chart setup: No clear chart pattern; technical signals are mixed. Earnings today. Wait until post-earnings. Target $134.94 (+6.7%), stop $111.70 (−13.2%), A.R:R 1.1:1. Score 6.3/10, moderate confidence.

What is the CVSA stock price target?

Take-profit target: $134.94 (+6.7% upside). Target $134.94 (+6.7%), stop $111.70 (−13.2%), A.R:R 1.1:1. Stop-loss: $111.70.

What are the risks of investing in CVSA?

Thin upside margin: 6.7%.

Is CVSA overvalued or undervalued?

Covista Inc. trades at a P/E of 16.5 (forward 12.6). TrendMatrix value score: 7.3/10. Verdict: Buy (Wait for Entry).

What do analysts say about CVSA?

10 analysts cover CVSA with a consensus score of 4.2/5. Average price target: $159.

What does Covista Inc. do?Covista is America's largest healthcare educator, serving 100,000 students and supported by an alumni network of...

Covista is America's largest healthcare educator, serving 100,000 students and supported by an alumni network of 400,000 across five accredited institutions: Chamberlain University ("Chamberlain"), Walden University ("Walden"), American University of the Caribbean School of Medicine ("AUC"), Ross University School of Medicine ("RUSM"), and Ross University School of Veterinary Medicine ("RUSVM"). Covista delivers education to its students at multiple campuses and online.

Related stocks: COUR (Coursera, Inc.) · PXED (Phoenix Education Partners, Inc) · LAUR (Laureate Education, Inc.) · LOPE (Grand Canyon Education, Inc.) · AFYA (Afya Limited)
Home › Stocks › CVSA

Latest news

Latest News

AlphaStreet92d ago
TipRanks92d agoRestructuring
Tipranks.com92d agoRestructuring
Newser183d ago
Yahoo Finance1d agoEarnings
MSN169d ago
Yahoo Finance169d ago
StockStory176d agoEarnings
The Globe and Mail85d agoEarnings
Business Wire85d agoRestructuring
StockStory85d agoEarnings
FinancialContent85d agoEarnings
TradingView93d agoRestructuring
Finviz93d agoLeadership Change
Investing.com Nigeria93d agoRestructuring
GuruFocus93d ago
Moomoo93d agoLeadership Change
Business Wire2d ago
Yahoo Finance170d ago
Yahoo Finance170d ago
Loading more...